SAN DIEGO, Oct. 4, 2001 (PRIMEZONE) -- Women First HealthCare, Inc. (Nasdaq:WFHC) today announced that Edward F. Calesa, chairman, president and CEO, will present at the annual UBS Warburg Global Life Sciences Conference. The Conference will be held Monday, Oct.8, 2001 through Friday, Oct. 12, 2001 at The Pierre Hotel in New York City.
Mr. Calesa's presentation is scheduled for Monday, Oct. 8, 2001, from 1-1:30 p.m. Eastern Time and will include discussion of business operations and strategic plans for the company.
During the five day Conference, over 400 companies from the United States, Europe and Australia in the biotechnology, life sciences and medical technology industries will present to an expected audience of over 2,000 attendees.
Mr. Calesa's presentation at the UBS Warburg Global Life Sciences Conference will be available to all interested parties through a live, listen-only telephone conference line on Oct. 8, 2001 at 1 p.m. Eastern Time. Live call access numbers are 1-800-500-0177 (domestic) and 1-719-457-2679 (international). Mr. Calesa's presentation will also be available via recorded telephone call option up to four weeks after the Conference. Recorded call access numbers for Monday, Oct. 8, 2001 UBS Warburg Global Life Sciences Conference presentations are 1-800-759-8603 (domestic) and 1-402-220-8537 (international). An audio prompt menu will direct callers to the Women First HealthCare presentation given by Mr. Calesa.
Mr. Calesa's UBS Warburg slide presentation will be available on the Company's Website at www.womenfirst.com by 1 p.m. Eastern Time on Monday, Oct. 8, within the Investor Relations, Interviews/Presentations area and will remain archived there for four weeks after the Conference.
About Women First HealthCare, Inc.
Women First HealthCare, Inc. (Nasdaq:WFHC) is a San Diego-based specialty pharmaceutical company. Founded in 1996, its mission is to help midlife women make informed choices regarding their health care and to provide pharmaceutical products -- the Company's primary emphasis -- and lifestyle products to meet their needs. Women First HealthCare is specifically targeted to women age 40+ and their clinicians. An internationally recognized Health Advisory Board of experts in women's health guides Women First HealthCare in the development of information and products for women and clinicians as women transition from perimenopause through postmenopause. The Company operates in three segments: Pharmaceuticals, Consumer Business, and Corporate Marketing. Product focus currently includes estrogen replenishment, headache management, dietary supplementation, and self-care/lifestyle. Further information about Women First HealthCare can be found online at www.womenfirst.com, About Us and Investor Relations. Information about the Company's As We Change(r) national mail order catalog and Internet retailer can also be found online at www.aswechange.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This press release may contain certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to various risks, and Women First HealthCare, Inc. cautions you that any forward-looking information is not a guarantee of future performance. Women First HealthCare, Inc. disclaims any intent or obligation to update these forward-looking statements. Actual results could differ materially due to a number of factors, including (i) we have incurred significant losses since we were founded in November 1996, and if midlife women do not use, and their clinicians do not recommend, the products we offer, we will continue to experience significant losses; (ii) there is a limited market awareness of our Company and the products and services we offer; (iii) we may not be able to identify appropriate licensing, co-promotion or acquisition candidates in the future or to take advantage of the opportunities we identify; (iv) we and our products face significant competition; (v) if we do not successfully manage any growth we experience, we may experience increased expenses without corresponding revenue increases; (vi) we are dependent on single sources of supply for all of the products we offer; and (vii) additional factors set forth in the Company's Securities and Exchange Commission filings including its Annual Report on Form 10-K for the period ended December 31, 2000 and its Form 10-Q for the period ended June 30, 2001.